Safety of SARS-CoV-2 Vaccines in Patients with Autoimmune Diseases

Abstract

Background: several vaccines have been developed against SARS-CoV-2 showing good safety profile. However, patients with autoimmune diseases or other conditions undergoing immunosuppressive treatments have been excluded from the clinical trials resulting in the approval of vaccines. Therefore, the safety profile of SARS-CoV-2 vaccines in this group of patients is unknown. The main was to analyze the short-term safety of vaccines against SARS-CoV-2 in